FasterCures SmartBrief

Tell a Friend

Complete the form below to send this FasterCures SmartBrief story to a colleague

* Your name:

* Your E-mail:

* Your friend's E-mail: Separate multiple addresses with commas
To access your saved contact list(s), you must log in.

Personal Message: (2000 characters at max)

(2000 characters left)

Terms and conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy.

More drug firms invest in vaccine R&D

Vaccines are catching up with prescription drugs as the most lucrative segment of the pharmaceutical business, as more biotech and drug firms invest in vaccine development. GlaxoSmithKline opened a vaccine-packaging plant in Pennsylvania in a bid to topple Merck & Co. as a global leader in vaccine manufacturing, while Johnson & Johnson plans to build a full vaccine portfolio that includes a universal flu shot and a vaccine for Alzheimer's disease. Google/The Associated Press (11/17)